Form 8-K - Current report:
SEC Accession No. 0001827506-25-000086
Filing Date
2025-06-09
Accepted
2025-06-09 08:11:12
Documents
60
Period of Report
2025-06-09
Items
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 8-K trml-20250609.htm   iXBRL 8-K 28378
2 EX-99.1 tourmalinecorporateoverv.htm EX-99.1 67707
6 tourmalinecorporateoverv001.jpg GRAPHIC 40018
7 tourmalinecorporateoverv002.jpg GRAPHIC 287174
8 tourmalinecorporateoverv003.jpg GRAPHIC 86603
9 tourmalinecorporateoverv004.jpg GRAPHIC 120085
10 tourmalinecorporateoverv005.jpg GRAPHIC 118400
11 tourmalinecorporateoverv006.jpg GRAPHIC 146607
12 tourmalinecorporateoverv007.jpg GRAPHIC 102190
13 tourmalinecorporateoverv008.jpg GRAPHIC 31100
14 tourmalinecorporateoverv009.jpg GRAPHIC 127112
15 tourmalinecorporateoverv010.jpg GRAPHIC 156101
16 tourmalinecorporateoverv011.jpg GRAPHIC 134941
17 tourmalinecorporateoverv012.jpg GRAPHIC 135941
18 tourmalinecorporateoverv013.jpg GRAPHIC 156765
19 tourmalinecorporateoverv014.jpg GRAPHIC 115804
20 tourmalinecorporateoverv015.jpg GRAPHIC 155011
21 tourmalinecorporateoverv016.jpg GRAPHIC 146203
22 tourmalinecorporateoverv017.jpg GRAPHIC 154090
23 tourmalinecorporateoverv018.jpg GRAPHIC 158353
24 tourmalinecorporateoverv019.jpg GRAPHIC 134180
25 tourmalinecorporateoverv020.jpg GRAPHIC 124975
26 tourmalinecorporateoverv021.jpg GRAPHIC 127747
27 tourmalinecorporateoverv022.jpg GRAPHIC 156482
28 tourmalinecorporateoverv023.jpg GRAPHIC 141081
29 tourmalinecorporateoverv024.jpg GRAPHIC 131494
30 tourmalinecorporateoverv025.jpg GRAPHIC 121747
31 tourmalinecorporateoverv026.jpg GRAPHIC 155057
32 tourmalinecorporateoverv027.jpg GRAPHIC 157685
33 tourmalinecorporateoverv028.jpg GRAPHIC 141170
34 tourmalinecorporateoverv029.jpg GRAPHIC 134089
35 tourmalinecorporateoverv030.jpg GRAPHIC 160660
36 tourmalinecorporateoverv031.jpg GRAPHIC 148957
37 tourmalinecorporateoverv032.jpg GRAPHIC 161716
38 tourmalinecorporateoverv033.jpg GRAPHIC 147887
39 tourmalinecorporateoverv034.jpg GRAPHIC 150461
40 tourmalinecorporateoverv035.jpg GRAPHIC 26792
41 tourmalinecorporateoverv036.jpg GRAPHIC 174579
42 tourmalinecorporateoverv037.jpg GRAPHIC 155270
43 tourmalinecorporateoverv038.jpg GRAPHIC 130107
44 tourmalinecorporateoverv039.jpg GRAPHIC 136767
45 tourmalinecorporateoverv040.jpg GRAPHIC 194864
46 tourmalinecorporateoverv041.jpg GRAPHIC 155920
47 tourmalinecorporateoverv042.jpg GRAPHIC 132122
48 tourmalinecorporateoverv043.jpg GRAPHIC 116824
49 tourmalinecorporateoverv044.jpg GRAPHIC 22115
50 tourmalinecorporateoverv045.jpg GRAPHIC 130920
51 tourmalinecorporateoverv046.jpg GRAPHIC 106266
52 tourmalinecorporateoverv047.jpg GRAPHIC 29610
  Complete submission text file 0001827506-25-000086.txt   8762656

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT trml-20250609.xsd EX-101.SCH 1800
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT trml-20250609_lab.xml EX-101.LAB 23449
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT trml-20250609_pre.xml EX-101.PRE 13593
62 EXTRACTED XBRL INSTANCE DOCUMENT trml-20250609_htm.xml XML 2915
Mailing Address 27 WEST 24TH STREET SUITE 702 NEW YORK NY 10010
Business Address 27 WEST 24TH STREET SUITE 702 NEW YORK NY 10010 646-481-9832
Tourmaline Bio, Inc. (Filer) CIK: 0001827506 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40384 | Film No.: 251032878
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)